The DOI matches its Crossref record; 85 of the 88 references it cites were found in a registry or an index.
International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer
Open accessAbstract
Background: Screening individuals at increased risk for pancreatic cancer (PC) detects early, potentially curable, pancreatic neoplasia. Objective: To develop consortium statements on screening, surveillance and management of high-risk individuals with an inherited predisposition to PC. Methods: A 49-expert multidisciplinary international consortium met to discuss pancreatic screening and vote on statements. Consensus was considered reached if ≥75% agreed or disagreed. Results: There was excellent agreement that, to be successful, a screening programme should detect and treat T1N0M0 margin-negative PC and high-grade dysplastic precursor lesions (pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm). It was agreed that the following were candidates for screening: first-degree relatives (FDRs) of patients with PC from a familial PC kindred with at least two affected FDRs; patients with Peutz–Jeghers syndrome; and p16 , BRCA 2 and hereditary non-polyposis colorectal cancer (HNPCC) mutation carriers with ≥1 affected FDR. Consensus was not reached for the age to initiate screening or stop surveillance. It was agreed that initial screening should include endoscopic ultrasonography (EUS) and/or MRI/magnetic resonance cholangiopancreatography not CT or endoscopic retrograde cholangiopancreatography. There was no consensus on the need for EUS fine-needle aspiration to evaluate cysts. There was disagreement on optimal screening modalities and intervals for follow-up imaging. When surgery is recommended it should be performed at a high-volume centre. There was great disagreement as to which screening abnormalities were of sufficient concern to for surgery to be recommended. Conclusions: Screening is recommended for high-risk individuals, but more evidence is needed, particularly for how to manage patients with detected lesions. Screening and subsequent management should take place at high-volume centres with multidisciplinary teams, preferably within research protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pancreas surveillance has been recommended for individuals estimated to be at high risk of developing PDAC (5% or higher estimated lifetime risk).5-8”
From The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival (2022) · cites this paper as [5]
In the citing paper
“The US Preventive Services Task Force and other guidelines recommend against screening for pancreatic ductal adenocarcinoma in asymptomatic adults at average risk.6,53,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“All screening programmes for pancreatic ductal adenocarcinoma aim to detect and treat T1N0M0 cancers or high-grade dysplastic premalignant lesions (ie, pancreatic intraepithelial neoplasia 3 or mucinous cystic tumours with high-grade dysplasia).6,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“This target includes individuals with at least two first-degree relatives with pancreatic ductal adenocarcinoma, patients with hereditary pancreatitis or particular genetic syndromes (eg, Peutz-Jeghers syndrome, or germline mutations in the CDKN2A, BRCA2, or PALB2),6,54 and individuals with mucinous cystic lesions of the pancreas.19–21”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
In the citing paper
“However, international guidelines and a white paper on the early detection of pancreatic ductal adenocarcinoma recommend targeted screening of individuals whose lifetime risk of developing pancreatic ductal adenocarcinoma is higher than 5% (figure 1).6,54”
From Early detection of pancreatic cancer (2020) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,077
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
Zauber, A. G., Winawer, S. J., O’Brien, M. J., Lansdorp‐Vogelaar, I., van Ballegooijen, M., Hankey, B. F., Shi, W., Bond, J. H., Schapiro, M., Panish, J. F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1100370 · Cited by 3,185
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Self-citationInternational consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
Tanaka, M., Fernández-del Castillo, C., Adsay, V., Chari, S., Falconi, M., Jang, J.-Y., Kimura, W., Levy, P., Pitman, M. B., Schmidt, C. M., et al. (2012) · Pancreatology · doi:10.1016/j.pan.2012.04.004 · Cited by 2,354
Tanaka, M., Chari, S. T., Adsay, V. N., Carlos, F.-D., Falconi, M., Shimizu, M., Yamaguchi, K., Yamao, K., & Matsuno, S. (2005) · Pancreatology · doi:10.1159/000090023 · Cited by 2,042
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
Winter, J. M., Cameron, J. L., Campbell, K. A., Arnold, M. A., Chang, D. C., Coleman, J., Hodgin, M. B., Sauter, P. K., Hruban, R. H., Riall, T. S., et al. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.08.018 · Cited by 1,491
Self-citationVery high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, G. J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,435
Self-citation
Cited by
Sorted by citations
Items 501–600 of 785
CTRC gene polymorphism may increase pancreatic cancer risk – preliminary study
Głuszek, S., Kowalik, A., Kozieł, D., Wawrzycka, I., Głuszek–Osuch, M., & Matykiewicz, J. (2017) · Polish Journal of Surgery · doi:10.5604/01.3001.0010.5411 · Cited by 5
Screening patients at high risk for pancreatic cancer—Is it time for a paradigm shift?
Lo, W. M., Morris, M. C., Ahmad, S. A., & Patel, S. H. (2019) · Journal of Surgical Oncology · doi:10.1002/jso.25616 · Cited by 5
Molecular Mechanisms of Cystic Neoplasia
Papadopoulos, N., & Hruban, R. H. (2018) · Wiley eBooks · doi:10.1002/9781119188421.ch75 · Cited by 5
Self-citationPrecision Prevention: The Current State and Future of Genomically Guided Cancer Prevention
Kassem, N., Stout, L. A., Hunter, C., Schneider, B., & Radovich, M. (2020) · JCO Precision Oncology · doi:10.1200/po.19.00278 · Cited by 5
Storman, M., & Czupryniak, L. (2025) · Cancers · doi:10.3390/cancers17182989 · Cited by 4
Ecoendoscopia digestiva na prática clínica parte IIa – utilidade na avaliação do pâncreas
Rodrigues, C. G., Pereira, E., Caldeira, A., Santos, A., Sousa, H., & Banhudo, A. (2014) · GE Portuguese Journal of Gastroenterology · doi:10.1016/j.jpg.2013.11.002 · Cited by 4
Surveillance of Pancreatic Ductal Adenocarcinoma in Chronic Pancreatitis: An Ongoing Challenge
Pongprasobchai, S. (2015) · Pancreatic Disorders and Therapy · doi:10.4172/2165-7092.1000149 · Cited by 4
Stoffel, E. M., Yurgelun, M. B. B., & Boland, C. R. (2018) · Springer eBooks · doi:10.1007/978-3-319-74259-5_1 · Cited by 4
Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening
Esmail, A., Badheeb, M. A., & Abdelrahim, M. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.110887 · Cited by 4
Fagundes, K. E. A., Montenegro, M. P., Peixoto, J. V. V., da Cruz, G. H. S., Lisboa, B. F., Pinheiro, J. S., de Oliveira, D. E., de Almeida, L. R. M., da Costa, L. M., Brito, T. V. A., et al. (2023) · Editora Acadêmica Periodicojs eBooks · doi:10.51249/easn17.2023.1530 · Cited by 4
Current Approaches of Pancreatic Cancer Surveillance in High-Risk Individuals
Heller, M., Mann, D. A., & Katona, B. W. (2025) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-025-01184-1 · Cited by 5
Gastroenterology and pancreatic adenocarcinoma: what the radiologist needs to know
Bhattacharya, A., Gandhi, N. S., Baker, M. E., & Chahal, P. (2017) · Abdominal Radiology · doi:10.1007/s00261-017-1347-5 · Cited by 4
Chao, D. T., Shah, N., Zeh, H. J., Singhi, A. D., Bahary, N., McGrath, K. M., Fasanella, K. E., Zureikat, A. H., Whitcomb, D. C., & Brand, R. E. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/2380596 · Cited by 4
Yoshikawa, T., Abe, T., Amano, H., Hanada, K., Minami, T., Kobayashi, T., Yonehara, S., Nakahara, M., Ohdan, H., & Noriyuki, T. (2018) · Surgical Case Reports · doi:10.1186/s40792-018-0492-6 · Cited by 4
Luz, L. P., Al‐Haddad, M., & DeWitt, J. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-22151-1.00015-3 · Cited by 4
Endoscopy and endosonography in the diagnostics of pancreatic cancer
Shishin, K., Bystrovskaya, E., Nedoluzhko, I., Kovalenko, D., Pronina, G., & Orlova, M. (2019) · Annaly khirurgicheskoy gepatologii = Annals of HPB surgery · doi:10.16931/1995-5464.2019336-44 · Cited by 2
From Screening to Treatment of Pancreatic Cancer: A Comprehensive Review.
Saif, M. W. (2021) · PubMed · Cited by 4
Role of 3D Volumetric and Perfusion Imaging for Detecting Early Changes in Pancreatic Adenocarcinoma
Rahmanuddin, S., Korn, R. L., Cridebring, D., Borazanci, E. H., Brase, J., Boswell, W. D., Jamil, A., Cai, W., Sabir, A., Motarjem, P. M., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.678617 · Cited by 4
Surgical management of familial pancreatic cancer: a systematic review of the literature
Bagias, G., Kanavidis, P., Vailas, M. G., Despotidis, M., Sotiropoulou, M. G., Katsaros, I., Maroulis, I. C., Filippou, D. K., & Schizas, D. (2022) · ANZ Journal of Surgery · doi:10.1111/ans.17834 · Cited by 4
Ashida, R., Ioka, T., Takada, R., Fukutake, N., Ikezawa, K., Ohkawa, K., Nagata, S., & Takahashi, H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.928182 · Cited by 4
Cai, J., Chen, H., Lu, M., Zhang, Y., Lu, B., Luo, C., Feng, X., You, L., Dai, M., & Zhao, Y. (2022) · Cancers · doi:10.3390/cancers14143403 · Cited by 4
Strategies for drug targeting in pancreatic cancer.
Sharma, N., & Arora, V. (2022) · Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · doi:10.1016/j.pan.2022.08.001 · Cited by 5
Somatic loss of ATM is a late event in pancreatic tumorigenesis
Paranal, R. M., Jiang, Z., Hutchings, D., Kryklyva, V., Gauthier, C., Fujikura, K., Nanda, N., Huang, B., Skaro, M. F., Wolfgang, C. L., et al. (2023) · The Journal of Pathology · doi:10.1002/path.6136 · Cited by 6
Self-citationLucas, A. L., Tarlecki, A., Beck, K. V., Lipton, C., RoyChoudhury, A., Levinson, E., Kumar, S., Chung, W. K., Frucht, H., & Genkinger, J. M. (2016) · Journal of Genetic Counseling · doi:10.1007/s10897-016-0057-4 · Cited by 4
Incidence of Pathogenic Variants in Those With a Family History of Pancreatic Cancer
Macklin, S., Kasi, P. M., Jackson, J. L., & Hines, S. L. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00330 · Cited by 4
Incidence and Mortality Rates of Second Pancreatic Cancer Among Survivors of Digestive Cancers
Ahn, H. S., Kang, T., Swan, H., Kang, M. J., Kim, N., Kim, H. J., & Park, S. M. (2019) · Pancreas · doi:10.1097/mpa.0000000000001254 · Cited by 4
Macgregor‐Das, A. M., & Goggins, M. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_56 · Cited by 4
Self-citationIdentification of genetic risk for pancreatic adenocarcinoma
Flores, K., Dinh, K. H., Rouleau, E., Whalen, G. F., Wassef, W. Y., & LaFemina, J. (2015) · Cancer Genetics · doi:10.1016/j.cancergen.2015.09.002 · Cited by 4
Advanced EUS Imaging for Early Detection of Pancreatic Cancer
Amin, S., DiMaio, C. J., & Kim, M. K. (2013) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2013.03.001 · Cited by 4
Germline CDKN 2A mutations in childhood melanoma: a case of melanoma–pancreatic cancer syndrome
Gironi, L. C., Colombo, E., Farinelli, P., Giorgione, R., Bozzola, C., Ogliara, P., & Pasini, B. (2015) · International Journal of Dermatology · doi:10.1111/ijd.12933 · Cited by 4
BRCA2‐associated pancreatic cancer and current screening guidelines
Kasi, P. M., Pedersen, K. S., & McWilliams, R. R. (2015) · Cancer · doi:10.1002/cncr.29447 · Cited by 4
Li, H., Lin, K., Reichert, M., Xu, L., Braren, R., Fu, D., Schmid, R. M., Li, J., Menze, B. H., & Shi, K. (2018) · arXiv (Cornell University) · doi:10.48550/arxiv.1806.01023 · Cited by 4
Roberts, N. J., & Klein, A. P. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_78-1 · Cited by 4
Abdel-Razeq, R. H., Mansour, A. H., Barbar, M., Shanap, M. A., Sharaf, B., Tamimi, F., Mansour, R. A., Muhanna, A., Al-Othman, Y. A., Hammad, H. T., et al. (2025) · Biologics · doi:10.2147/btt.s543427 · Cited by 3
Yahia, S. B., Lam, A. V. D. W., Cabuta, M., Nielsen, M., & Helderman, N. C. (2026) · International Journal of Cancer · doi:10.1002/ijc.70381 · Cited by 3
Pancreatic Cancer Mimicking Relapse of Autoimmune Pancreatitis: Case Reports
Kojima, H., Kitago, M., Iwasaki, E., Masugi, Y., Abe, Y., Hasegawa, Y., Hori, S., Tanaka, M., Nakano, Y., Edanami, M., et al. (2025) · Surgical Case Reports · doi:10.70352/scrj.cr.25-0076 · Cited by 3
Traitement médical du cancer du pancréas : en 10 ans, enfin des progrès
Hammel, P. R., Neuzillet, C., Bendaoud, S., Lekhal, C., de Mestier, L., & Hentic, O. (2015) · Bulletin du Cancer · doi:10.1016/s0007-4551(15)31219-4 · Cited by 3
Pancreatic Cancer Screening: What We Do and Do Not Know
Bhutani, M. S., Thosani, N. C., Suzuki, R., & Guha, S. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.004 · Cited by 3
Isayama, H., Nakai, Y., & Draganov, P. V. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2013.009 · Cited by 3
The Early Detection of Pancreatic Cancer: Whom and How?
Ryu, J. K. (2015) · The Korean Journal of Pancreas and Biliary Tract · doi:10.15279/kpba.2015.20.4.198 · Cited by 3
Pancreatic cancer: current understanding of molecular and genetic aetiologies
Gall, T., Wasan, H. S., & Jiao, L. R. (2015) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2014-133161 · Cited by 3
Diagnosis and Management of Hereditary Pancreatic Cancer
Humphris, J. L., & Biankin, A. V. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-29998-3_5 · Cited by 3
State-Of-The-Art Endoscopic Procedures for Pancreatic Cancer
Coronel, E. S., & Waxman, I. (2016) · Future Oncology · doi:10.2217/fon-2016-0123 · Cited by 3
Update on Management Periampullary/Pancreatic Head Cancer
Tewari, M., Swain, J. R., & Mahendran, R. (2020) · Indian Journal of Surgery · doi:10.1007/s12262-019-02053-5 · Cited by 3
Inherited predisposition to pancreatic cancer
Hilfrank, K. J., Rustgi, S. D., & Kastrinos, F. (2021) · Seminars in Oncology · doi:10.1053/j.seminoncol.2021.02.006 · Cited by 3
Kumar, S., Santos, R. J., McGuigan, A. J., Singh, U., Johnson, P. A., Kunzmann, A. T., & Turkington, R. C. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0616 · Cited by 3
Roch, A. M., Kim, R. C., Nguyen, T. K., House, M. G., Zyromski, N. J., Nakeeb, A., Schmidt, C. M., & Ceppa, E. P. (2023) · Journal of Surgical Oncology · doi:10.1002/jso.27289 · Cited by 3
Kaçar, A. K., Aylar, D., Kazdal, F., & Bahadorı, F. (2023) · Toxicology in Vitro · doi:10.1016/j.tiv.2023.105609 · Cited by 3
Pancreatic Cancer Screening among High-risk Individuals
Turner, K. M., & Patel, S. H. (2024) · Surgical Clinics of North America · doi:10.1016/j.suc.2024.03.002 · Cited by 3
Hallenstein, L. G., Sorensen, C., Hodgson, L., Wen, S., Westhuyzen, J., Hansen, C. J., Last, A. J., Amalaseelan, J., Salindera, S., Ross, W., et al. (2021) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-021-00176-z · Cited by 3
Familial pancreatic cancer: who should be considered for genetic testing?
Kartal, K., Guan, Z., Tang, R., Griffin, M., Wang, Y., Braun, D., Klein, A. P., & Hughes, K. S. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02572-9 · Cited by 3
Association of BRCA Mutations and Pancreatic Cancer
Chandan, S., Deliwala, S. S., Facciorusso, A., Mohan, B. P., Ramai, D., & Kochhar, G. S. (2022) · Pancreas · doi:10.1097/mpa.0000000000001956 · Cited by 3
Akushevich, I. V., Yashkin, A. P., Kovtun, M., YASHIN, A. I., & Kravchenko, J. S. (2022) · Cancer Causes & Control · doi:10.1007/s10552-022-01595-6 · Cited by 3
Campbell, F., & Verbeke, C. S. (2013) · Springer eBooks · doi:10.1007/978-1-4471-2449-8_6 · Cited by 3
Wáng, Y. X. J., Gong, J., & Loffroy, R. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.1000-9604.2015.06.09 · Cited by 3
Iskandar, M., Wayne, M. G., Steele, J. G., & Cooperman, A. M. (2014) · Case Reports in Oncological Medicine · doi:10.1155/2014/737183 · Cited by 3
Genetic Counseling and Testing for Hereditary Melanoma: An Updated Guide for Dermatologists
Champine, M. (2012) · Hereditary Genetics · doi:10.4172/2161-1041.s2-004 · Cited by 3
Sey, M. S. L., DeWitt, J. M., & Al‐Haddad, M. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2320-5_30 · Cited by 3
Mauro, L. A., Herman, J. M., Jaffee, E. M., & Laheru, D. A. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00081-3 · Cited by 3
Noë, M., Hackeng, W. M., de Leng, W. W. J., Vergeer, M., Vleggaar, F. P., Morsink, F. H. M., Wood, L. D., Hruban, R. H., Offerhaus, G. J. A., & Brosens, L. A. A. (2019) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001314 · Cited by 4
Self-citationSensitive multi-photon nonlinear laser wave-mixing detection of cancer and heart failure biomarkers
Liang, J., Suprapto, J., Crawford, S., & Tong, W. G. (2019) · Novel Optical Systems, Methods, and Applications · doi:10.1117/12.2529899 · Cited by 3
Prediction of Pancreatic Cancer Risk and Therapeutic Response with Next-Generation Sequencing
Kyrochristos, I. D., Ziogas, D. E., Glantzounis, G. K., & Roukos, D. H. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0315 · Cited by 3
Progress report: familial pancreatic cancer
Mintziras, I., & Bartsch, D. K. (2019) · Familial Cancer · doi:10.1007/s10689-019-00125-9 · Cited by 3
Haan, D., Bergamaschi, A., Guler, G. D., Friedl, V., Ning, Y., Reggiardo, R. E., Kesling, M., Collins, M., Gibb, B., Pitea, A., et al. (2021) · medRxiv · doi:10.1101/2021.12.27.21268450 · Cited by 3
Nellen, J. R., Strickland, A. G., & Yeo, C. J. (2018) · Journal of Pancreatic Cancer · doi:10.1089/pancan.2018.0012 · Cited by 2
Fukuba, N., Ishitobi, H., Takahashi, Y., Nagaoka, M., Fukuhara, H., Yuki, M., Komazawa, Y., Kuroda, H., Satō, S., & Shizuku, T. (2020) · Pancreas · doi:10.1097/mpa.0000000000001653 · Cited by 2
Grindedal, E. M., Zucknick, M., Hovland, S. T., Grimsrud, T. K., & Mæhle, L. (2025) · BJC Reports · doi:10.1038/s44276-025-00199-2 · Cited by 3
Pancreatic Ductal Adenocarcinoma Treatment—The Past, Present, and Future
Lavu, H., & Yeo, C. J. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.12.001 · Cited by 2
Chao, D. T., Shah, N., Zeh, H. J., Bahary, N., Whitcomb, D. C., & Brand, R. E. (2015) · Pancreas · doi:10.1097/mpa.0000000000000439 · Cited by 2
Chen, X., Yu, Z., Wang, J., Cui, W., Cui, C., Wang, Y., Liu, Y., Zhou, H., Wang, C., Wang, Z., et al. (2021) · Cancer Management and Research · doi:10.2147/cmar.s327022 · Cited by 2
Pankreaskarzinom – Screening oder Surveillance?
Sirtl, S., Vornhülz, M., Hofmann, F. O., Mayerle, J. V., & Beyer, G. (2023) · Die Radiologie · doi:10.1007/s00117-023-01227-3 · Cited by 2
Bogdanski, A. M., Onnekink, A. M., Inderson, A., Boekestijn, B., Bonsing, B. A., Vasen, H. F. A., van Hooft, J. E., Boonstra, J. J., Mieog, J. S. D., Wasser, M. N. J. M., et al. (2024) · Pancreas · doi:10.1097/mpa.0000000000002335 · Cited by 2
Survival benefit associated with screening of patients at elevated risk for pancreatic cancer
Kane, W. J., Haden, K., Martin, E. N., Shami, V. M., Wang, A. Y., Strand, D. S., Adair, S. J., Nagdas, S., Tsung, A., Zaydfudim, V. M., et al. (2024) · Journal of Surgical Oncology · doi:10.1002/jso.27784 · Cited by 2
RNA biosensors for detection of pancreatic cancer.
Zare-Mehrjardi, M.-J., Hatami-Araghi, M., Jafari-Khorchani, M., Roudsari, Z. O., Taheri-Anganeh, M., Abdolrahmat, M., Ghasemi, H., & Aiiashi, S. (2025) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/j.cca.2025.120237 · Cited by 2
Endoscopic Ultrasound in Pancreatic Cancer: The New Perspective
Seicean, A. (2014) · InTech eBooks · doi:10.5772/57182 · Cited by 1
The Prevention and Genetics of Pancreatic Cancer: A Programmatic Approach
Lucas, A. L., Chang, M. M., Lipsyc, M. D., & Frucht, H. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-287-2_10 · Cited by 2
Familial Breast Cancer and Genetic Predisposition in Breast Cancer
Walavalkar, V., Khan, A. A., & Kandil, D. H. (2015) · Molecular pathology library · doi:10.1007/978-1-4939-2886-6_2 · Cited by 2
Sequencing Pancreatic Juice: Squeezing the Most Out of Surveillance
Lipner, M. B., & Yeh, J. J. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0215 · Cited by 2
Precious Data: Interim Report from the Jefferson Pancreas Tumor Registry
Yeo, T. P., Lavu, H., Nevler, A., Brumbaugh, J. L., Vicchairelli, D., Winter, J. M., Brody, J. R., & Yeo, C. J. (2018) · Journal of Pancreatic Cancer · doi:10.1089/pancan.2018.0004 · Cited by 2
Primary and Secondary Prevention of Pancreatic Cancer
Yu, A., Romero, T., & Genkinger, J. M. (2019) · Current Epidemiology Reports · doi:10.1007/s40471-019-00189-2 · Cited by 2
Kahlert, C., Distler, M., Aust, D. E., Gieldon, L., Weitz, J., & Welsch, T. (2017) · Der Chirurg · doi:10.1007/s00104-017-0569-y · Cited by 2
Therapeutic vaccines for pancreatic cancer
Tekkeşin, N., & Tetik, Ş. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819457-7.00014-1 · Cited by 2
Role of routine check-up in the prognosis of patients with pancreatic cancer: A puzzling phenomenon
Song, C., Shen, Y., & Lu, Y. (2020) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2020.06.009 · Cited by 2
Belozerov, V. A., Okhotnikov, O. I., Korenevskiy, N. A., & Grigorev, S. N. (2021) · Journal of oncology diagnostic radiology and radiotherapy · doi:10.37174/2587-7593-2021-4-3-64-73 · Cited by 2
Recomendaciones para el diagnóstico y tratamiento del adenocarcinoma ductal de páncreas
Pasqua, A. V., Moro, M., Alle, L., Basso, S., Canicoba, M., Capitanich, P., Carballido, M., Cayol, F., Crisci, J., Fernández, D., et al. (2020) · Acta gastroenteorológica latinoamericana/Acta gastroenterológica latinoamericana · doi:10.52787/xaqm8690 · Cited by 2
Familial Gastric and Pancreatic Cancers: Diagnosis and Screening
Raymond, V. M., & Stoffel, E. M. (2013) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbook_am.2013.33.e44 · Cited by 2
Peters, M. L. B., Eckel, A. L., Lietz, A., Seguin, C. L., Mueller, P. P., Hur, C., & Pandharipande, P. V. (2022) · Pancreatology · doi:10.1016/j.pan.2022.05.003 · Cited by 2
Xia, C., Yin, H., Zhang, K., Wang, Z., Yang, X., & Huang, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.980415 · Cited by 2
Novel Considerations in Surgical Management of Individuals with Pancreatic Adenocarcinoma
Barnes, C. A., & Tsai, S. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.07.004 · Cited by 2
Early screening of Pancreatic Cancer: A Bibliometric Study Over the Past Two Decades
Ma, G.-X., Wang, Y., Liu, Y., Mao, X., Mao, S.-H., Xiong, S.-H., Li, Z., Hou, L., & Zou, W. (2023) · Cancer Screening and Prevention · doi:10.14218/csp.2023.00022 · Cited by 2
Gao, L., Ugalde, A., Livingston, P. M., WHITE, V. M., Watts, J. J., Jongebloed, H., McCaffrey, N., Menzies, D., & Robinson, S. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-10722-9 · Cited by 2
Prostate cancer in a man with a BRCA2 mutation and a personal history of bilateral breast cancer
Singer, C. F., Rappaport, C., Sopik, V., & Narod, S. A. (2014) · Clinical Genetics · doi:10.1111/cge.12478 · Cited by 2
Inherited Gene Mutations in Melanoma
Pho, L. N., Champine, M., Leachman, S. A., & Kohlmann, W. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3554-3_5 · Cited by 2
Hereditary Pancreatitis – A Review of Current Concepts and Management
Hughes, D., Gordon-Weeks, A. N., & Silva, M. A. (2019) · OBM Hepatology and Gastroenterology · doi:10.21926/obm.hg.1903028 · Cited by 2
Hereditäre Tumorerkrankungen – Diagnostik und Überwachungsstrategien
Rädle, J. (2020) · Springer eBooks · doi:10.1007/978-3-662-58879-6_9 · Cited by 2
Molero, X., Ayuso, J. R., Balsells, J., Boadas, J., Busquets, J., Casteràs, A., Concepción, M., Cuatrecasas, M., Fernández‐Esparrach, G., Fort, E., et al. (2021) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2021.05.003 · Cited by 2
Khashab, M. A., & Canto, M. I. (2015) · Yamada's Textbook of Gastroenterology · doi:10.1002/9781118512074.ch146 · Cited by 2
Self-citationA multi-analyte serum biomarker panel for early detection of pancreatic adenocarcinomaPreprint
Firpo, M. A., Boucher, K. M., Bleicher, J. M., Khanderao, G. D., Rosati, A., Poruk, K. E., Kamal, S., Marzullo, L., Marco, M. D., Falco, A., et al. (2022) · medRxiv · doi:10.1101/2022.03.03.22271867 · Cited by 2
Klein, A. P. (2018) · doi:10.1002/9781119188421.ch91 · Cited by 2
Molecular Mechanisms of Cystic Neoplasia‐
Papadopoulos, N., & Hruban, R. H. (2023) · Wiley eBooks · doi:10.1002/9781119876007.ch82 · Cited by 2
Self-citation
Metadata
- Authors
- Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., Levy, M. J., Chak, A., Fockens, P., Goggins, M., & Bruno, M.
- Affiliations
- Johns Hopkins University (US)
- Erasmus MC (NL)
- Utrecht University (NL)
- Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands
- Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
- University of Verona (IT)
- Amsterdam UMC Location University of Amsterdam (NL)
- Mayo Clinic (US)
- University Hospitals of Cleveland (US)
- Corresponding author
- Canto, Marcia Irene
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2012-11-07
- Volume
- 62
- Issue
- 3
- Pages
- 339-347
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC3585492
- OpenAlex
- W2111705409
- Cited by
- 784
- References
- 88
- Citations by year
- 2026: 23 · 2025: 23 · 2024: 40 · 2023: 53 · 2022: 66 · 2021: 73 · 2020: 61 · 2019: 82 · 2018: 82 · 2017: 67 · 2016: 71 · 2015: 69 · 2014: 45 · 2013: 23 · 2012: 6
- FWCI
- 22.79
- Type
- journal article
- Language
- en
- Update notices
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Gut (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Cancer Institute (K24CA113433, P30CA006973)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- pancreatic cancer screening, familial pancreatic cancer, genetic susceptibility, pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, Peutz-Jeghers syndrome, BRCA2 mutation carriers, Lynch syndrome, endoscopic ultrasound, surveillance interval, surgical management, high-volume centers, multidisciplinary team, consensus recommendations
- MeSH terms
- Age Factors, Carcinoma, Follow-Up Studies, Humans, Mutation, Pancreatectomy, Pancreatic Neoplasms, Pedigree, Risk Factors, Treatment Outcome, Endosonography, Genetic Predisposition to Disease, Cholangiopancreatography, Magnetic Resonance, Early Detection of Cancer, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
